AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2018
May 19, 2018
30583_dirs_2018-05-18_2967ff3c-e9ea-429a-a970-19db0d34ce6b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2018-05-17
Reporting Person: MEIER RICHARD A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-05-17 | Common Stock | M | 15000 | $38.59 | Acquired | 51310 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-05-17 | Stock Option (Right to buy) Common Stock | $38.59 | M | 15000 | Disposed | 2018-05-21 | Common Stock (15000) | Direct |
Footnotes
F1: Reflects the number of options outstanding after the transactions from this specific stock option grant.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19